IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Knoll Capital Management, LLC

Q4 2018 Holdings

Filed 2019-02-14 | 15 holdings | $5.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aldeyra Therapeutics Inc(ALDX)COM01438T106$4.0M484,09674.6%
Anavex Life Sciences Corp(AVXL)COM NEW032797300$1.1M724,20521.0%
Chromadex Corp(NAGE)COM NEW171077407$154.0K45,0192.9%
Biohaven Pharmactl Hldg Co L(BHVN)COMG11196105$27.7K749,8150.5%
Corbus Pharmaceuticals Hldgs(CRBPEUR)COM21833P103$23.7K4,062,7910.4%
Abeona Therapeutics Inc(ABEO1EUR)COM00289Y107$16.8K2,359,7670.3%
Krystal Biotech Inc(KRYS)COM501147102$6.2K300,0000.1%
Electrocore Inc(ECORGBP)COM28531P103$2.5K396,8250.0%
Entera Bio Ltd(ENTX)SHSM40527109$1.5K475,5400.0%
Galmed Pharmaceuticals Ltd(GLMD)SHSM47238106$1.4K210,0000.0%
Eiger Biopharmaceuticals Inc(CLDNEUR)COM28249U105$76475,2380.0%
Soligenix Inc.COM834223307$721837,8000.0%
Evoke Pharma IncCOM30049G104$682275,0000.0%
Molecular TemplatesCOM608550109$460113,9050.0%
Lipocine Inc NewCOM53630X104$6550,0000.0%